investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Defining Response and Resistance to PI3K and AR inhibition in Prostate Cancer
Brett Stewart Carver
0 Collaborator(s)
Funding source
National Institutes of Health (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
Brett Stewart Carver
Memorial Sloan Kettering Cancer Center
New York, United States
Related projects
Michael Bustin
Biological Functions of Chromosomal Proteins
Prostate
Pediatric oncology or childhood cancer
Radiation Oncology
Steven P. Balk
Androgen Receptor Action in Castration Resistant Prostate Cancer
Prostate
Stefan Ambs
The Molecular Profile of Prostate Tumors in African-American Men
Prostate
Pathology
Philip Tofilon
Radiation-induced translational control of gene expression
Prostate
Radiation Oncology
Karen E Knudsen
USP22 Function in Advanced Prostate Cancer
Prostate
Pathology
Harry Ostrer
Genomics and Predictive Modeling of Prostate Cancer Heath Disparity
Prostate
Jeffrey Green
Transgenic Models for Prostate and Breast Cancer
Prostate
Anne E Cress
Human Prostate Cancer Metastasis and Laminin Binding Integrins
Prostate
Pathology
Clinton Kylie Matson
Exploiting the Genomic Programs Underlying AR-Independent Prostate Cancer
Prostate
Pathology
